Octreotide Injection
|
Generic Name |
|
|---|---|
|
Strength |
|
|
Form |
|
|
Packaging |
|
|
Therapeutic use |
Accessories |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Oxymetazoline Nasal Solution | 0.01 % w / v, 0.025 % w / v, 0.05 % w / v | Anti-Allergic, Antihistamine, Nasal decongestant | |
| Oxcarbazepine Tablet | 150 mg, 300 mg, 450 mg, 600 mg | Anti-epilepsy, Seizures | |
| Ornidazole Tablet | 500 mg | Anthelmintic, Anti Parasitic, Anti Protozoal, Antibiotic | |
| Ornidazole Infusion | 500 mg / 100 ml | Analgesic | |
| Ondansetron Tablet | 4 mg, 8 mg | Antiemetic | |
| Ondansetron Suspension | 2 mg / 5 ml | Antiemetic | |
| Omeprazole Injection | 40 mg | Anti Ulcer, GIT Agent | |
| Omeprazole Capsule | 20 mg, 40 mg | Anti Ulcer, GIT Agent | |
| Omeprazole and Domperidone Capsule | 20 mg + 10 mg | Anti Ulcer, GIT Agent | |
| Olopatadine Eye Drop | 0.1 % w/v | Anti-Allergic, Anti-Inflammatory, Antihistamine | |
| Olopatadine and Ketorolac Eye Drop | 0.1 % w/v + 0.4 % w/v | NSAIDS | |
| Olmesartan Medoxomil Tablet | 10 mg, 20 mg, 40 mg | Cardiovascular Agent | |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablet | 20 mg + 12.5 mg, 40 mg + 25 mg | Cardiovascular Agent | |
| Olanzapine Tablet | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg | Anti Anxiety, Anti Psychotic, Antidepressant, CNS Agent | |
| Ofloxacin Ornidazole Terbinafine and Clobetasol Cream | 0.75 % w/w + 2 % w/w + 1 % w/w + 0.05 % w/w | Antifungal, Antibiotic, Skin Care | |
| Ofloxacin, Clotrimazole, Beclomethasone and Lignocaine Ear Drop | 0.3 % w/v + 1 % w/v + 0.025 % w/v + 2 % w/v | Analgesic |
Product Description For Octreotide Injection
products details and uses
Octreotide Exporter India, Manufacturer, Wholesaler & Distributor
Octreotide Injection is a synthetic somatostatin analogue used for the effective management of several serious medical conditions. It is primarily prescribed for the treatment of acromegaly (a hormonal disorder resulting from excess growth hormone), carcinoid tumors, and bleeding esophageal varices. Additionally, Octreotide is used to help prevent complications following pancreatic surgery, particularly to reduce the risk of pancreatic fistulas and other postoperative issues.
The medication works by mimicking natural somatostatin, inhibiting the release of various hormones and substances such as growth hormone, serotonin, and insulin-like growth factors.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Octreotide to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey